Overview
Ads (0)
PPC Keywords (0)
Organic Keywords (8,521)
Competitors (721)
Sub-Domains
1. |
be inc |
18 |
68,000,000 |
$1.81 |
10.07 |
8.04 |
4 |
1,220,000,000 |
http://www.centerwatch.com/news-online/2016/07/29/alistair-macdonald-incs-new-ceo/ |
|
2. |
en tabs |
17 |
45,500,000 |
$1.22 |
6.74 |
3.63 |
0 |
2,920,000 |
http://www.centerwatch.com/drug-information/fda-approved-drugs/drug/176/azulfidine-en-tabs-tablets-sulfasalazine-delayed-release-tablets-usp |
|
3. |
the ich |
10 |
20,400,000 |
$0.56 |
6.04 |
1.49 |
0 |
465,000,000 |
http://www.centerwatch.com/news-online/2016/08/01/update-e6-ich-gcp-guideline/ |
|
4. |
who registry |
6 |
20,400,000 |
$1.43 |
6.04 |
3.81 |
0 |
18,400,000 |
http://www.centerwatch.com/news-online/2007/08/01/china-and-india-join-who-registry-database/ |
|
5. |
trials for |
2 |
5,000,000 |
$1.53 |
5.55 |
3.75 |
0 |
75,500,000 |
https://www.centerwatch.com/clinical-trials/listings/condition/45/chronic-pain |
|
6. |
for 2005 |
11 |
24,900,000 |
$1.22 |
5.53 |
2.98 |
0 |
6,930,000,000 |
https://www.centerwatch.com/drug-information/fda-approved-drugs/year/2005 |
|
7. |
by training |
19 |
55,600,000 |
$4.27 |
4.12 |
7.75 |
0 |
2,030,000,000 |
http://www.centerwatch.com/news-online/2017/02/01/parexel-recognized-2017-training-top-125-training-magazine/ |
|
8. |
new for 2008 |
1 |
1,220,000 |
$2.38 |
2.26 |
2.37 |
0 |
2,660,000,000 |
https://www.centerwatch.com/drug-information/fda-approved-drugs/year/2008 |
|
9. |
overview of a |
18 |
9,140,000 |
$1.18 |
1.35 |
0.70 |
0 |
926,000,000 |
http://www.centerwatch.com/clinical-trials/overview.aspx |
|
10. |
clinical trials |
2 |
823,000 |
$2.75 |
0.91 |
1.11 |
60 |
67,500,000 |
https://www.centerwatch.com/clinical-trials/listings/location/united-states/VA/ |
|
ascSort Ascending
descSort Descending
eqEquals...
!eqDoes Not Equal...
gtGreater Than...
gteqGreater Than or Equal To...
ltLess Than...
lteqLess Than or Equal To...